Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Canada / NCT07648498
Starting soon Not applicable

Feasibility of a Community-Integrated Isometric Handgrip Exercise Program and Its Preliminary Effects on Blood Pressure and Cognitive Function in Older Adults

NCT07648498 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-07-28
Last updated
2026-06-15

Condition(s) studied

HypertensionElevated Blood Pressure

Investigational drug(s) / intervention(s)

Zona Plus 4-Week Isometric Handgrip Exercise InterventionSquegg 4-Week Isometric Handgrip Exercise Intervention

Zona Plus 4-Week Isometric Handgrip Exercise Intervention: This intervention consists of a supervised, low-dose isometric handgrip exercise program delivered over 4 weeks using the Zona Plus handgrip dynamometer. Participants will complete two sessions per week, each consisting of 4x2-minute isometric handgrip contractions performed at 30% of maximal voluntary contraction, with 1-minute rest periods between contractions. Contractions will be performed using alternating hands. All sessions will be conducted in person and supervised by trained research staff at the Physical Activity Centre of Excellence, and the intervention will completed before participants' existing exercise routines. Ratings of perceived exertion will be recorded following each contraction.

Squegg 4-Week Isometric Handgrip Exercise Intervention: This intervention consists of a supervised, low-dose isometric handgrip exercise program delivered over 4 weeks using the Squegg handgrip device. Participants will complete two sessions per week, each consisting of 4x2-minute isometric handgrip contractions performed at 30% of maximal voluntary contraction, with 1-minute rest periods between contractions. Contractions will be performed using alternating hands. All sessions will be conducted in person and supervised by trained research staff at the Physical Activity Centre of Excellence, and the intervention will completed before participants' existing exercise routines. Ratings of perceived exertion will be recorded following each contraction.

Study summary

The goal of this clinical trial is to evaluate whether a short, supervised isometric handgrip exercise program is feasible and acceptable for older adults with elevated blood pressure or hypertension. It will also explore whether this type of exercise may improve blood pressure and cognitive function.

The main questions it aims to answer are:

* Is this handgrip exercise program practical and acceptable for older adults to participate in within a community exercise setting?
* Does participation in the program lead to changes in blood pressure and cognitive function?

Researchers will compare two handgrip devices to determine whether the method of delivering the exercise influences feasibility and outcomes.

Participants will:

* Be randomly assigned to use one of two handgrip devices.
* Complete supervised exercise sessions twice per week for 4 weeks.
* Perform brief handgrip contractions at a set intensity during each session.
* Complete blood pressure and cognitive assessments before and after the program.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 65 years of age or older * Currently attending the Physical Activity Centre of Excellence at McMaster University * English speaking * Diagnosed with hypertension or elevated blood pressure Exclusion Criteria: * Current or prior participation in chronic isometric exercise * Unstable angina. * Uncontrolled hypertension * Uncontrolled heart failure and/or arrhythmias * Recent myocardial infarction or electrocardiography changes * Complete heart block * Carpal tunnel syndrome * Arthritis that may be aggravated by handgrip exercise * Changes to the type and/or dose of blood pressure medications within 3 months of starting the study.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
NeuroFit Lab, Ivor Wynne Centre, McMaster University Hamilton Ontario
Physical Activity Centre of Excellence, Ivor Wynne Centre, McMaster University Hamilton Ontario

More McMaster University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07648498 on ClinicalTrials.gov ↗ ← All trials in Canada